Brief: Phathom Pharmaceuticals To Place A Part Of $300 Million Financing Agreement In Non-Dilutive Capital
01/11/2022 12:52
Nov 1 (Reuters) - Hercules Capital Inc HTGC.N :
* PHATHOM PHARMACEUTICALS ANNOUNCES PLACEMENT OF THE
REMAINING $40
MILLION IN NON-DILUTIVE CAPITAL UNDER ITS UP TO $300 MILLION
REVENUE INTEREST FINANCING AGREEMENT
Source text for Eikon: ID:nGNX4KpHZg
Further company coverage: HTGC.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hercules Capital
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Broadening credit concerns driving BDC weakness, KBW says
Brief: Hercules Capital Prices Upsized Institutional Notes Offering Of $400.0 Million 6.70% Notes Due 2029
Hercules Capital Q2 investment income rises to record high
Brief: Hercules Capital Closes Institutional Notes Offering Of $325.0 Million 6.300% Unsecured Notes Due 2031